Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Chronic Obstructive Pulmonary Disease|January 8, 2015
Effect of severe renal impairment on umeclidinium and umeclidinium/vilanterol pharmacokinetics and safety: a single-blind, nonrandomized studyRashmi Mehta, Kelly Hardes, Noushin Brealey, et al.
Pulmonary Pharmacology & Therapeutics|May 17, 2019
Efficacy and safety of the dual bronchodilator combination umeclidinium/vilanterol in COPD by age and airflow limitation severity: A pooled post hoc analysis of seven clinical trialsRiju Ray, Lee Tombs, Ian Naya, et al.
Clinical Pharmacology in Drug Development|June 23, 2015
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vilanterol, a Novel Inhaled Long-Acting β-Agonist, in Children Aged 5-11 Years with Persistent Asthma: A Randomized TrialAmanda Oliver, Sandi VanBuren, Ann Allen, et al.
Clinical Pharmacology in Drug Development|April 30, 2016
Safety, tolerability, pharmacokinetics, and pharmacodynamics of fluticasone furoate, a novel inhaled corticosteroid, in children aged 5-11 years with persistent asthma: A randomized trialAmanda Oliver, Ann Allen, Sandi VanBuren, et al.
Advances in Therapy|November 1, 2016
Assessing Short-term Deterioration in Maintenance-naïve Patients with COPD Receiving Umeclidinium/Vilanterol and Tiotropium: A Pooled Analysis of Three Randomized TrialsM Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto, et al.
Clinical Therapeutics|May 6, 2014
Tolerability of fluticasone furoate/vilanterol combination therapy in children aged 5 to 11 years with persistent asthmaAmanda Oliver, Sandi VanBuren, Ann Allen, et al.
Drugs & Aging|June 29, 2018
Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled TrialsRiju Ray, Lee Tombs, Michael J Asmus, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 23, 2016
Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterolDave Singh, M Reza Maleki-Yazdi, Lee Tombs, et al.
ERJ Open Research|January 12, 2018
Effects of umeclidinium/vilanterol on exercise endurance in COPD: a randomised studyJohn H Riley, Chris J Kalberg, Alison Donald, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|November 12, 2024
The Effect of Patient Sex on Treatment Outcomes in COPD: A Post Hoc Analysis of the IMPACT TrialAlejandra Hernández Alberola, Natalia Bartolomé Nogal, Almudena Blanco Miranda, et al.
Pageof 5